Viela Bio, Inc. Common Stock
VIE
VIE was delisted on the 12th of March, 2021.
38 hedge funds and large institutions have $516M invested in Viela Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$116M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$111M |
| 3 |
Temasek Holdings
Singapore
|
+$103M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$37.7M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$37.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $226K | +$210K | +8,342 | New |
|
27
UBS Group
Zurich,
Switzerland
| $183K | +$170K | +6,734 | New |
|
28
New York State Common Retirement Fund
Albany,
New York
| $133K | +$123K | +4,900 | New |
|
|
AIG
29
American International Group
New York
| $93K | +$86.2K | +3,420 | New |
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $53K | +$50.6K | +2,006 | New |
|
|
SO
31
STRS Ohio
Columbus,
Ohio
| $38K | +$35.3K | +1,400 | New |
|
32
Citigroup
New York
| $30K | +$27.6K | +1,096 | New |
|
33
Legal & General Group
London,
United Kingdom
| $29K | +$27.4K | +1,087 | New |
|
34
Bank of America
Charlotte,
North Carolina
| $23K | +$21.3K | +847 | New |
|
35
Bank of Montreal
Toronto,
Ontario, Canada
| $19K | +$17.4K | +689 | New |
|
|
AIP
36
Ameritas Investment Partners
Lincoln,
Nebraska
| $13K | +$11.8K | +469 | New |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | +$10.2K | +403 | New |
|
38
Wells Fargo
San Francisco,
California
| – | +$123K | +4,869 | New |
|
VIE Hedge Fund Activity: Q4 2019 in Review
38 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q4 2019, worth a combined $516M.
Buyers outnumbered sellers: 38 funds opened new VIE positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HHLR Advisors, opening a new position worth an estimated $116M.
- 38 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $516M of Viela Bio, Inc. Common Stock stock for Q4 2019.
- 38 funds opened new Viela Bio, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +38 holders.
- The largest Viela Bio, Inc. Common Stock buyer in Q4 2019 was HHLR Advisors, an estimated $116M added.
Based on aggregated 13F filings for Q4 2019.